Diagnostic challenges, management, and outcome of infants born to mothers with COVID 19 during the first wave of the pandemic.
COVID 19
breastfeeding
neonate
pregnant women
transmission of infection
Journal
Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
30
08
2021
accepted:
29
09
2021
entrez:
3
1
2022
pubmed:
4
1
2022
medline:
4
1
2022
Statut:
ppublish
Résumé
Severe acute respiratory distress syndrome with coronavirus 2 (SARS-CoV-2) infection affected pregnant women during the pandemic. Immunological particularity of this population and the increased need for medical assistance placed this population in a high-risk category for SARS-Cov-2 infection. Owing to high contamination risk and limited studies regarding vertical transmission, the labor and delivery of positive women required particular conditions. Cesarean section probably proved to be the optimal option for delivery of infants to reduce the risk of infection during birth. The aim of the present study was to present the management and outcome of infants born to mothers confirmed with coronavirus disease 2019 (COVID 19) prior to delivery. This is a longitudinal, retrospective study, analyzing demographics, laboratory data and management of neonates born to mothers with diagnosis of SARS-Cov-2 infection. The results showed that 5 neonates were born to SARS-Cov-2-positive mothers, all by Cesarean section and had a negative reverse transcription-quantitative polymerase chain reaction (RT-qPCR) test. None of the women breastfed during the hospital stay. The negative RT-qPCR test allowed us to reduce the hospital stay of infants and care in non-isolated areas. In summary, in the present study, vertical or perinatal transmission of the infection was not present. The testing of the pregnant women, their isolation and delivery in safe conditions for the medical staff were possible, with the latter using adequate protection equipment to limit their infection and the risk for the newborns.
Identifiants
pubmed: 34976144
doi: 10.3892/etm.2021.11025
pii: ETM-0-0-11025
pmc: PMC8674959
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102Informations de copyright
Copyright: © Zaharie et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Zhonghua Fu Chan Ke Za Zhi. 2020 Mar 25;55(3):166-171
pubmed: 32145714
Am J Obstet Gynecol. 2020 Aug;223(2):284-286
pubmed: 32348743
Clin Infect Dis. 2020 Jul 28;71(15):844-846
pubmed: 32119083
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
J Med Virol. 2020 Jun;92(6):564-567
pubmed: 32115733
Arch Acad Emerg Med. 2020 Mar 23;8(1):e34
pubmed: 32232217
JAMA Pediatr. 2020 Jul 1;174(7):722-725
pubmed: 32215598
Transl Pediatr. 2020 Feb;9(1):51-60
pubmed: 32154135
Int J Mol Med. 2020 Jul;46(1):3-16
pubmed: 32377694
N Engl J Med. 2020 May 28;382(22):2163-2164
pubmed: 32283004
J Med Virol. 2020 Sep;92(9):1556-1561
pubmed: 32222119
J Med Virol. 2020 Apr;92(4):408-417
pubmed: 31944312
Int J Mol Med. 2020 Jun;45(6):1631-1643
pubmed: 32236624
Lancet Infect Dis. 2020 May;20(5):559-564
pubmed: 32220284
Am J Obstet Gynecol MFM. 2020 May;2(2):100110
pubmed: 32518901
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
JAMA. 2020 May 12;323(18):1846-1848
pubmed: 32215581